Hodgkin's Lymphoma News

• 'Unexpected': Age 35 Key to Ovarian Function After Chemo for HL Age impacts recovery of ovarian function after chemotherapy for Hodgkin's lymphoma, even when regimens considered less toxic are used.
  Medscape Medical News, October 2018
• Risk of Second Primary Cancer on the Rise in People With HIV
  Reuters Health Information, September 2018
• Czech Beer Is Designed for Cancer Patients' Tastes The nonalcoholic beer has fewer hops, which reduces bitterness, and is diluted with apple juice for sweetening. Clinicians in the Czech Republic, where beer is the national drink, are handing it out to breast cancer patients.
  Medscape Medical News, July 2018
• Young Cancer Survivors at Higher Risk for Endocrine Diseases Adolescent and young adult survivors are at highest risk for thyroid disease, testicular dysfunction, and diabetes. Authors of a large study call for better surveillance of this underserved group.
  Medscape Medical News, July 2018
• EHA 2018First-in-Class Drug Against CD79b Improves Survival in DLBCL The first-in-class antibody-drug conjugate polatuzumab vedotin significantly improved response and overall survival in relapsed or refractory diffuse large B-cell lymphoma.
  Medscape Medical News, June 2018
• EHA 2018Vitamin D Deficiency and Reduced Hodgkin Lymphoma Survival A large study has found that patients with Hodgkin lymphoma who showed baseline deficiencies in vitamin D had significantly shorter progression-free and overall survival.
  Medscape Medical News, June 2018
• Non-AIDS Cancers Expected to Dominate in HIV-infected Adults by 2030
  Reuters Health Information, May 2018
• EU OK for Generic Carmustine for Brain Tumors and Lymphoma A generic version of carmustine has been recommended for approval in the European Union, as have indication extensions for several cancer drugs.
  Medscape Medical News, April 2018
• After 1400% Price Hike, Generic Cancer Drug in Spotlight Skyrocketing prices for some generic drugs have garnered increased attention, and lomustine is the latest to be scrutinized by the federal government
  Medscape Medical News, April 2018
• Alert FDA Approval Tweaks Decades-Old Treatment of Hodgkin's Lymphoma The approval adds to the indications with which brentuximab can used in the treatment of classic Hodgkin's lymphoma.
  FDA Approvals, March 2018
• AACR 2018Successful CAR T-Cell Tx Needs Good T Cells to Begin With Starting with poor-quality T cells may be a key problem in the manufacturing of effective and functional CAR T cells, which may explain why it has been difficult to apply this approach to all cancers.
  Medscape Medical News, March 2018
• For Cancer, Cannabis Has Many Virtues, Says Large Study It's an observational study and cannot demonstrate causality, but new data from Israel indicate that cannabis may improve a range of common symptoms among cancer patients.
  Medscape Medical News, March 2018
• Cancer Survival Unaffected by England's National Cancer Plan Overall short-term cancer survival and socioeconomic inequalities seem to have been unaffected by a 5-year national cancer initiative in England to boost care delivery.
  Medscape Medical News, March 2018
• CSSIncreased Risk for CVD in Some Cancer Survivors Now that cancer survivors are living longer, other health concerns, such as cardiovascular disease (CVD), become of concern.
  Medscape Medical News, February 2018
• New Guidelines for Treating Checkpoint Inhibitor Toxicities ASCO and the NCCN have issued joint guidelines for treating toxicities associated with checkpoint inhibitor treatment.
  Medscape Medical News, February 2018
• CSSNo Follow-up in More Than a Third of AYA Cancer Survivors A large proportion of adolescent and young adult (AYA) cancer survivors are not receiving follow-up care after the end of their active treatment.
  Medscape Medical News, February 2018
• After Lymphoma, Risk for Breast Cancer Differs by Subtype The risk of developing estrogen-receptor-negative breast cancer following Hodgkin's lymphoma is increased regardless of prior radiotherapy.
  Medscape Medical News, January 2018
• ASHFirst in 30 Years: Improved Front Line in Hodgkin's Lymphoma Brentuximab vedotin has already made an impact on the management of relapsed/refractory classical Hodgkin's lymphoma. Now the drug is poised for frontline use.
  Medscape Medical News, December 2017
• Living in Very Cold Climate and Increased Cancer Risk A study demonstrating the environmental impact on natural selection of genetic variants for survival supports a 'long-standing' hypothesis about the origins of cancer.
  Medscape Medical News, December 2017
• Alert EU Panel Likes Biosimilar Bevacizumab, Other Cancer Agents The Committee for Medicinal Products for Human Use has issued a new list of recommendations and rejections for oncology products.
  International Approvals, November 2017